M1196 HCPCS Reimbursement & Policy Benchmarks | OpenPayer

Summary & Overview

HCPCS Level II M1196: Initial Itch/Symptom Severity Assessment (NRS/VRS/ItchyQuant)

HCPCS Level II code M1196 captures an initial (index visit) patient-reported symptom severity assessment—using a numeric rating scale (NRS), visual rating scale (VRS), or ItchyQuant—with a score of greater than or equal to 4. As a discrete code for baseline symptom burden, it supports clinical documentation and downstream care planning for moderate-to-severe itch or related symptom complaints. Nationally, clear use of this code helps standardize reporting of symptom severity at the first visit and can influence care pathways, utilization tracking, and quality measurement.

Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical intent and typical settings of use, a summary of payer coverage considerations, and context for how the code fits into symptom assessment workflows. The publication outlines common modifiers associated with procedural reporting, notes where input data is missing, and links the code to clinical documentation practices.

This summary is intended for a national audience of clinicians, billing professionals, and policy analysts seeking a focused briefing on the purpose, setting, and reporting implications of HCPCS Level II code M1196. Data not available in the input is identified where relevant.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareM1196HCPCS Level IIitch assessmentnumeric rating scalevisual rating scaleItchyQuantoutpatient assessmentdermatology billingsymptom severity

Billing Code Overview

HCPCS Level II code M1196 describes an initial (index visit) assessment using a numeric rating scale (NRS), visual rating scale (VRS), or ItchyQuant assessment with a score greater than or equal to 4. This indicates documentation of a baseline symptom severity assessment at the first visit when the reported score meets or exceeds the threshold.

Service type: Symptom severity assessment and initial clinical evaluation.

Typical site of service: Ambulatory clinic or outpatient dermatology or allergy practice where initial patient-reported itch or symptom severity is collected and documented.

Clinical & Coding Specifications

Clinical Context

A 52-year-old patient presents to an outpatient dermatology clinic with a three-month history of moderate-to-severe pruritus associated with chronic eczematous dermatitis. The initial evaluation includes history, focused skin exam, and administration of a standardized patient-reported outcome instrument to quantify itch severity. The clinician records an initial numeric rating scale (NRS), visual rating scale (VRS), or ItchyQuant score and documents a score of greater than or equal to 4, indicating clinically significant itch. The encounter typically occurs in ambulatory dermatology or primary care settings and is billed as an evaluation component that documents symptom severity to guide topical or systemic therapy initiation and to support follow-up planning. Typical workflow: triage nurse or medical assistant administers the scale, clinician reviews and documents the score in the medical record, links the score to the diagnosis (for example, atopic dermatitis or pruritus, unspecified), and the billing/coding specialist applies the M1196 HCPCS Level II code for the initial index visit assessment when the score is ≥4.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required is substantially greater than typically required for this service due to complexity of evaluation or documentation beyond the usual scope.

HCPCS Level II M1295: Total Colectomy or Colorectal Cancer History

HCPCS-M1362-PATIENTS-DIED-DURING-MEASUREMENT-PERIOD

HCPCS Level II M1362: Patients Who Died During the Measurement Period

HCPCS-M1178-DOCUMENTATION-PNEUMOCOCCAL-VACCINE-EXEMPTION

HCPCS M1178: Documentation of Medical Reason Not to Administer Pneumococcal Vaccine

HCPCS-M1257-CVD-RISK-ASSESSMENT-NOT-PERFORMED-OR-INCOMPLETE

HCPCS Level II M1257: CVD Risk Assessment Not Performed or Incomplete

HCPCS-M1199-RENAL-REPLACEMENT-THERAPY-SERVICES

HCPCS M1199: Renal Replacement Therapy Services

HCPCS-M1194-PATHOLOGY-NO-MMR-MSI-TESTING-DOCUMENTED

HCPCS M1194: Documentation of Absent or Deferred MMR/MSI Testing

HCPCS-M1466-LUMBAR-FUSION-WITH-DISCECTOMY-LAMINECTOMY

HCPCS Level II M1466: Lumbar Fusion with Discectomy/Laminectomy

HCPCS-M1422-GASTROENTEROLOGY-MIPS-VALUE-PATHWAY

HCPCS M1422: Gastroenterology Care MIPS Value Pathway

HCPCS-M1212-GLYCEMIC-STATUS-ASSESSMENT-MISSING

HCPCS M1212: Glycemic Status Assessment Missing

HCPCS-M1169-INFLUENZA-VACCINE-MEDICAL-EXEMPTION-DOCUMENTATION

HCPCS M1169: Documentation of Medical Reason for Not Administering Influenza Vaccine

Showing 1–10 of 356

Taxonomy Code	Specialty	Notes
`207N00000X`	Dermatology	Most common specialty performing itch severity assessments and initial dermatologic evaluations.
`207Q00000X`	Allergy & Immunology	Performs evaluations for chronic pruritus when allergic or immunologic etiologies are suspected.
`207L00000X`	Family Medicine	Common in primary care settings where initial itch assessment and management occur.
`207R00000X`	Internal Medicine	Provides initial assessment and systemic workup for chronic itch in adult patients.
`261QM0800X`	Pain Management	May assess itch severity in patients with neuropathic pruritus or chronic pain syndromes.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L29.9`	Pruritus, unspecified	Common presenting diagnosis for patients with significant itch quantified by NRS/VRS/ItchyQuant.
`L20.9`	Atopic dermatitis, unspecified	Atopic dermatitis frequently causes moderate-to-severe pruritus warranting standardized severity assessment.
`L23.9`	Allergic contact dermatitis, unspecified	Contact dermatitis often results in itch; scoring guides treatment decisions.
`L30.9`	Dermatitis, unspecified	General dermatitis diagnoses associated with pruritus where an initial itch score is relevant.
`N35.0`	Pruritus of scrotum (example of localized pruritus)	Localized pruritus diagnoses where scoring severity supports targeted therapy.
`B84`	Scabies	Parasitic infestations cause intense pruritus and are commonly assessed with severity scales.
`R21`	Rash and other nonspecific skin eruption	When rash presents with itch, initial quantification helps triage and management.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99401`	Preventive medicine counseling, individual; approximately 15 minutes	May be reported when brief counseling on skin care, avoidance measures, or topical therapy is provided alongside the itch severity assessment.
`99203`	Office or other outpatient visit for the evaluation and management of a new patient, low to moderate complexity	Common E/M code for an initial office visit during which the NRS/VRS/ItchyQuant assessment is performed and documented.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically low to moderate complexity	Used for follow-up visits where itch severity is reassessed and documented.
`97001`	Physical therapy evaluation	May be relevant when physical modalities are considered for neuropathic pruritus and an interdisciplinary evaluation occurs.
`99406`	Smoking and tobacco use cessation counseling, intermediate, greater than 3 minutes up to 10 minutes	May be reported if counseling on modifying contributing behaviors (e.g., smoking-related skin issues) is provided during the visit.

OpenPayer